The Assistance Fund
Independent nonprofit providing copay/premium assistance via 100+ disease funds to ensure insured patients access life-changing treatments.
Visit WebsiteKnown For
Manages ~100 disease funds covering all FDA-approved treatments per disease (not single-drug)
Key Differentiators
- Manages ~100 disease funds covering all FDA-approved treatments per disease (not single-drug)
- advanced tech platform for efficient reimbursements/claims processing
- high transparency (GuideStar Platinum, 94% of donations to patients)
Overview
The Assistance Fund (TAF) is an independent 501(c)(3) nonprofit that provides financial assistance to insured patients with chronic, rare, and life-threatening diseases to cover out-of-pocket costs like copays, coinsurance, deductibles, premiums, travel, and tests. It manages nearly 100 disease-specific programs, each covering all FDA-approved treatments for the named condition, funded by donations including from pharmaceutical companies compliant with anti-kickback laws. TAF reimburses eligible patients directly, helping pharma companies indirectly by supporting adherence for their Medicare patients who cannot receive direct copay aid.
Services & Capabilities
- Copay/coinsurance/deductible assistance, health insurance premium assistance, treatment-related travel costs, diagnostic lab/genetic testing, incidental medical expenses
- via ~100 disease-specific programs covering all FDA-approved treatments per disease
Competitive Position
- Manages ~100 disease funds covering all FDA-approved treatments per disease (not single-drug)
- advanced tech platform for efficient reimbursements/claims processing
- high transparency (GuideStar Platinum, 94% of donations to patients)
Recent Developments
Ranked #76 on Forbes’ 100 Largest U.S. Charities list (2025); new copay assistance program for bronchiectasis; recognized as one of the Best Non-Profits to Work For; board additions (Frank Montes De Oca, John Wagner in 2025); hiring announcements. No major M&A, partnerships, or funding rounds reported.
Client & Partner Ecosystem
Pharma donors (e.g., Teva, Biogen, Novartis per past DOJ settlement); competitors/partners like PAN Foundation, HealthWell Foundation
Technology Platform
Leading technology platform (for patient reimbursements, document parsing, CRM, provider portal)
Therapeutic Focus
broad/all (nearly 100 programs including oncology, rare diseases, autoimmune, neurology, e.g., breast cancer, bronchiectasis, hereditary angioedema, infantile spasms, macular degeneration)
Target Customers
Pharmaceutical companies (donors), patients (end-users), healthcare providers
Sources
Similar Vendors
Accessia Health
Nonprofit providing comprehensive financial aid, case management, and legal support to rare/chronic disease patients beyond copays.
Apollo Care
Tech-driven copay, hub, and analytics solutions optimizing pharma patient access and commercial performance.
Asembia
Largest U.S. specialty pharmacy GPO with 35,000+ pharmacy network, integrated hub services, and the industry's dominant annual conference (AXS Summit) — the gateway to the specialty pharmacy ecosys...
AssistRx
Technology-first patient access platform backed by WCAS, delivering measurable time-to-therapy reductions through direct payer connectivity and EHR-integrated digital intake.
Atlantis Health
Global partner delivering behavior science-powered patient engagement solutions to boost adherence and outcomes for pharma across the health journey.
Authenticx
AI-powered conversation intelligence turning healthcare interactions into actionable patient and compliance insights at scale.